Ibex Exim Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 14 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 4.21%
- Profit Growth -0.50%
- Ebitda -58.87%
- Net Worth 21.75%
- Total Assets -6.90%
About Ibex Exim
Ibex Exim Private Limited (IEPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 May 2010 and has a history of 14 years and nine months. Its registered office is in Chandigarh, India.
The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jagan Sharma, Dipty Manchanda, and Sunidhi Dogra serve as directors at the Company.
Company Details
- Location
Chandigarh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51101CH2010PTC032214
- Company No.
032214
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 May 2010
- Date of AGM
30 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Ibex Exim?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jagan Sharma  | Director | 22-Aug-2022 | Current |
| Dipty Manchanda | Director | 24-Jan-2014 | Current |
| Sunidhi Dogra | Director | 01-Feb-2021 | Current |
Financial Performance of Ibex Exim.
Ibex Exim Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.21% increase. The company also saw a slight decrease in profitability, with a 0.5% decrease in profit. The company's net worth Soared by an impressive increase of 21.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ibex Exim?
In 2023, Ibex Exim had a public holding of 21.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ranbhav Engineers Pvt. Ltd.Jagan Sharma and Sunidhi Dogra are mutual person
- Kayms Fiscal Solutions Private Limited
Jagan Sharma and Sunidhi Dogra are mutual person
- Indicaps Healthcare Private Limited
Dipty Manchanda is a mutual person
- Ramadeus Capsules Private Limited
Dipty Manchanda is a mutual person
- Elinza Pharmaceuticals Private Limited
Dipty Manchanda is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ibex Exim?
Unlock and access historical data on people associated with Ibex Exim, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ibex Exim, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ibex Exim's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
